Frydman Valentine, Pinar Ugo, Abdessater Maher, Akakpo William, Grande Pietro, Audouin Marie, Mozer Pierre, Chartier-Kastler Emmanuel, Seisen Thomas, Roupret Morgan
Department of Urology, Sorbonne Université, GRC n 5, Predictive Onco-Urology, APHP, Hôpital Pitié-Salpêtrière, F-75013, Paris, France.
Department of Urology, Sorbonne Université, APHP, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix, F-75013, Paris, France.
Basic Clin Androl. 2021 Mar 4;31(1):4. doi: 10.1186/s12610-021-00123-x.
Penile prothesis (PP) is the gold-standard treatment of drug-refractory erectile dysfunction (ED). While postoperative outcomes have been widely described in the literature, there are few data about patient satisfaction and intraoperative events. We aimed to assess long-term patient satisfaction and perioperative outcomes after PP implantation in a single-centre cohort of unselected patients using validated scales.
A total of 130 patients received a PP (median age: 62.5 years [IQR: 58-69]; median International Index of Erectile Function (IEEF-5) score: 6 [IQR: 5-7]). Median follow-up was 6.3 years [IQR: 4-9.4]. Thirty-two (24.6%) patients underwent surgical revision, of which 20 were PP removals (15.4%). Global PP survival rate was 84.6% and previous PP placement was a risk factor for PP removal (p = 0.02). There were six (4.6%) non-life-threatening intraoperative events including two which resulted in non-placement of a PP (1.5%). EAUiaic grade was 0 for 124 procedures (95.4%), 1 for four procedures (3.1%) and 2 for two procedures (1.5%). Of patients who still had their PP at the end of the study, 91 (80.5%) expressed satisfaction.
PP implantation is a last-resort treatment for ED with a satisfactory outcome. PPs are well accepted by patients.
阴茎假体（PP）是药物难治性勃起功能障碍（ED）的金标准治疗方法。虽然术后结果在文献中已有广泛描述，但关于患者满意度和术中事件的数据却很少。我们旨在使用经过验证的量表，评估在一个未选择患者的单中心队列中，PP植入术后的长期患者满意度和围手术期结果。
共有130例患者接受了PP植入（中位年龄：62.5岁[四分位间距：58 - 69]；国际勃起功能指数（IEEF - 5）中位评分：6[四分位间距：5 - 7]）。中位随访时间为6.3年[四分位间距：4 - 9.4]。32例（24.6%）患者接受了手术翻修，其中20例为PP取出（15.4%）。PP的总体生存率为84.6%，既往PP植入是PP取出的一个危险因素（p = 0.02）。有6例（4.6%）非危及生命的术中事件，其中2例导致未植入PP（1.5%）。124例手术（95.4%）的欧洲泌尿外科学会（EAU）阴茎假体植入后并发症分级为0级，4例手术（3.1%）为1级，2例手术（1.5%）为2级。在研究结束时仍保留PP的患者中，91例（80.5%）表示满意。
PP植入是ED的一种最终治疗手段，效果令人满意。PP被患者广泛接受。
